Neuralink’s Blindsight may soon restore peoples’ eyesight

Neuralink’s Blindsight may soon restore peoples’ eyesight

/ 09:09 AM September 19, 2024

Elon Musk’s Neuralink announced his Blindsight project received the “Breakthrough Device” designation from the US Food and Drug Administration.

It is a brain-computer interface or implant that will allegedly enable the blind to see again, even those with zero vision since birth. 

READ: Neuralink raises ethical concerns among scientists

Article continues after this advertisement

Interesting Engineering says similar technologies have long been supporting partially-sighted persons. However, Neuralink differs by adding more electrodes to boost visual acuity theoretically.

How does the Blindsight work?

Elon Musk says Blindsight works by bypassing damaged optic nerves and directly stimulating the visual cortex with microelectrodes. 

The visual cortex is the brain area responsible for processing visual information. The tech billionaire compared its early-stage vision quality to video game graphics from the Atari console. 

Article continues after this advertisement

In March 2024, the CEO stated that his company had tested the brain control interface on monkeys successfully. 

Article continues after this advertisement

The FDA Breakthrough Device designation is a voluntary program for medical devices that provide more effective treatment or diagnosis of severe health conditions. 

Article continues after this advertisement

His X post or tweet above claims Blindsight “will enable even those who have lost both eyes and their optic nerve to see.” 

The designation may help Musk conduct human trials for the device to further improve it. However, he has yet to develop it into an effective cure for blindness. 

Article continues after this advertisement

University of Washington Psychology Professors Ione Fine and Geoffrey Boynton shared their skepticism with Blindsight on The Conversation. 

They stated Musk’s claim that the brain’s neurons are akin to on-screen pixels is a “fallacy.”

Nevertheless, Blindsight is Neuralink’s latest attempt to push the boundaries of science and technology. 

Its first implant was a success, allowing research participant Noland Arbaugh to play chess with his mind.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Learn more about it in this Inquirer Tech article.

TOPICS: Blindness, Health, Health and Science, technology, Top Stories Home
TAGS: Blindness, Health, Health and Science, technology, Top Stories Home

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.